|
|
|
Stem Cell Related Patent Number US6632424
| Title: | Human FLTS3 ligand | | Inventors: | Lyman, Stewart D.; Seattle, WA, USA
Beckmann, Patricia M.; Poulsbo, WA, USA | | Summary: | Described herein are isolated ligands for flt 3 receptors. The invention relates to ligands for flt3 receptors which are capable of transducing self-renewal signals to regulate the growth, proliferation or differentiation of progenitor and stem cells. Further disclosed are properties of flt3-L as an isolated protein, the DNA encoding the flt3-L, host cells transfected with cDNAs encoding flt3-L, compositions comprising flt3-L, methods of improving gene transfer to a mammal using flt3-L, and methods of improving transplantations using flt3-L. Therapeutic applications are included, such as in the treatment of anemia, AIDS and various cancers. | | Abstract: | Ligands for flt3 receptors capable of transducing self-renewal signals to regulate the growth, proliferation or differentiation of progenitor cells and stem cells are disclosed. The invention is directed to flt3-L as an isolated protein, the DNA encoding the flt3-L, host cells transfected with cDNAs encoding flt3-L, compositions comprising flt3-L, methods of improving gene transfer to a mammal using flt3-L, and methods of improving transplantations using flt3-L. Flt3 -L finds use in treating patients with anemia, AIDS and various cancers. | | US Patent Website: | Click Here for Full Text of Patent | | Title Number: | US6632424 | | Application Number: | US1995000444626 | | Date Filed: | 19/05/1995 | | Date Published: | 14/10/2003 | | Assignee: | Immunex Corporation, Seattle, WA, USA |
|
|
